Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.
Open | $4.330 |
Close | $4.440 |
Volume / Avg. | 511.357K / 678.543K |
Day Range | 4.230 - 4.510 |
52 Wk Range | 2.689 - 7.795 |
Market Cap | $274.268M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 4.21% |
Days to Cover | 2.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Inozyme Pharma (NASDAQ: INZY) through any online brokerage.
Other companies in Inozyme Pharma’s space includes: Renovaro (NASDAQ:RENB), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT) and Monte Rosa Therapeutics (NASDAQ:GLUE).
The latest price target for Inozyme Pharma (NASDAQ: INZY) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 23.00 expecting INZY to rise to within 12 months (a possible 418.02% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Inozyme Pharma (NASDAQ: INZY) is $4.44 last updated April 26, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Inozyme Pharma.
Inozyme Pharma’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Inozyme Pharma.
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.